Validation of the Histologic Risk Model in a New Cohort of Patients With Head and Neck Squamous Cell Carcinoma

Abstract

We demonstrate significant predictive performance of the risk model in a new cohort of patients with primary HNSCC, adjusted for confounders. Our training experience also supports the feasibility of adapting the risk model in clinical practice.